A star Chinese researcher laid off by Facebook owner Meta Platforms has co-founded a start-up focused on self-improving artificial intelligence systems, joining a wave of US and Chinese firms developing models capable of autonomously refining their own code and reasoning. Tian Yuandong, former research scientist director at Meta’s FAIR (Fundamental AI Research) team, launched Recursive Superintell...
A star Chinese researcher laid off by Facebook owner Meta Platforms has co-founded a start-up focused on self-improving artificial intelligence systems, joining a wave of US and Chinese firms developing models capable of autonomously refining their own code and reasoning. Tian Yuandong, former research scientist director at Meta’s FAIR (Fundamental AI Research) team, launched Recursive Superintelligence alongside seven other co-founders. The company said on Wednesday it had raised more than...
ProArtWork/iStock Unreleased via Getty Images Investment Thesis Even though Pfizer Inc. ( PFE ) is down 2.7% since my last coverage , it seems to finally be showing signs that the post-COVID reset may be bottoming out. Investors have been punishing Pfizer stock because of declining vaccine sales, worries about the debt load, and upcoming patent expiration. However, the business itself is stabilizi...
ProArtWork/iStock Unreleased via Getty Images Investment Thesis Even though Pfizer Inc. ( PFE ) is down 2.7% since my last coverage , it seems to finally be showing signs that the post-COVID reset may be bottoming out. Investors have been punishing Pfizer stock because of declining vaccine sales, worries about the debt load, and upcoming patent expiration. However, the business itself is stabilizing after two years of punishment from the stock market. Acquisitions in oncology and specialty care appear to grow fast enough to counter the decline of key sales. Investors have been waiting a while, admittedly, but operationally Pfizer looks much healthier than the stock price suggests right now. Data by YCharts Operational Growth in Acquired Assets Targets Revenue Expirations In Q1, Pfizer generated $14.5 billion in revenues, which represents a 5.7% YoY increase, and it beats estimates by $649.06 million . At the bottom line, diluted EPS hit 75 cents and exceeded estimates by 3 cents. In my analysis of the components forming this revenue, I am observing an expansion in products Pfizer acquired and launched, as this group derived $3.1 billion in revenues during Q1. This performance equates to 22% operational growth, and extrapolating this performance yields an annual run rate over $12 billion. Pfizer modeled $17 billion of topline exposed to losses of exclusivity before FY30. The expansion in products Pfizer acquired addresses this gap as Oncology assets integrated from Seagen hit 20% operational growth YoY. With that, Nurtec volume expanded 41%, and Eliquis sales increased 13% YoY, reaching $2.17 billion and beating estimates of $1.93 billion. Q1 Earnings Moreover, a settlement concerning Vyndamax patents delays generic market entry for this asset. Vyndamax derives over $6 billion annually, and the settlement extends exclusivity into mid-FY31. Delaying generic entry reduces the FY28 to FY30 topline exposure from $17 billion to a range of $14 billion to $15 billion. Now, ...
Getty Images The affordability of new homes in the U.S. improved in March 2026 as builder incentives to reduce the sale prices of new homes combined with relatively low mortgage rates and a rising income for the typical American household . The first two of these factors directly reduced the typical mortgage payment for U.S. households, while the third makes the lower cost for owning a new home mo...
Getty Images The affordability of new homes in the U.S. improved in March 2026 as builder incentives to reduce the sale prices of new homes combined with relatively low mortgage rates and a rising income for the typical American household . The first two of these factors directly reduced the typical mortgage payment for U.S. households, while the third makes the lower cost for owning a new home more affordable by definition for the nation's median income-earning household. Here are the applicable numbers: Median new home sale price: $387,400 Median household income: $87,164 Average 30-year conventional fixed mortgage rate: 6.18% For that household at the exact middle of the U.S. income spectrum, the average mortgage payment for a new home purchased at the national median sale price with zero percent down would consume 32.6% of the household's monthly income in March 2026. This value falls in between the two major affordability thresholds mortgage lenders have traditionally used in the form of the 28/36 rule to determine whether to extend a mortgage to new home buyers. The following chart shows how March 2026's level of relative affordability for new homes compares with the affordability for every month from January 2000 through March 2026: In March 2026, buying a new home was the most affordable it has been in the U.S. for a typical American household at any time in the last four years. References U.S. Census Bureau. New Residential Sales Historical Data. Houses Sold. [ Excel Spreadsheet ]. Accessed 5 May 2026. U.S. Census Bureau. New Residential Sales Historical Data. Median and Average Sale Price of Houses Sold. [ Excel Spreadsheet ]. Accessed 5 May 2026. Freddie Mac. 30-Year Fixed Rate Mortgages Since 1971. [ Online Database ]. Accessed 11 May 2026. Note: Starting from December 2022, the estimated monthly mortgage rate is taken as the average of weekly 30-year conventional mortgage rates recorded during the calendar month. Original Post Editor's Note: The summary...
Ironclad, the AI contracting company accelerating business with every contract, today announced the appointment of Mike Jordan as the company's new Chief People Officer.
Ironclad, the AI contracting company accelerating business with every contract, today announced the appointment of Mike Jordan as the company's new Chief People Officer.
PALO ALTO, Calif., May 14, 2026--Nectar Social today announced a $30 million Series A led by Menlo Ventures and its Anthology Fund, created in partnership with Anthropic, with participation from True Ventures, GV (Google Ventures), and Gwyneth Paltrow’s Kinship Ventures. Founded by two sisters, Misbah and Farah Uraizee, both former Meta leaders, Nectar emerged from stealth in 2025. The company is ...
PALO ALTO, Calif., May 14, 2026--Nectar Social today announced a $30 million Series A led by Menlo Ventures and its Anthology Fund, created in partnership with Anthropic, with participation from True Ventures, GV (Google Ventures), and Gwyneth Paltrow’s Kinship Ventures. Founded by two sisters, Misbah and Farah Uraizee, both former Meta leaders, Nectar emerged from stealth in 2025. The company is also officially launching its Nectar Agent - the autonomous AI agent for modern marketing, available
US Govt Settles With Former NYT Reporter In Biden/Twitter Censorship Case Authored by Zachary Stieber via The Epoch Times, The U.S. government has reached a settlement with a former New York Times reporter who was kicked off Twitter during the COVID-19 pandemic for posts about vaccines. Officials in a settlement agreement dated May 11 and obtained by The Epoch Times said that the government “did i...
US Govt Settles With Former NYT Reporter In Biden/Twitter Censorship Case Authored by Zachary Stieber via The Epoch Times, The U.S. government has reached a settlement with a former New York Times reporter who was kicked off Twitter during the COVID-19 pandemic for posts about vaccines. Officials in a settlement agreement dated May 11 and obtained by The Epoch Times said that the government “did in fact violate the First Amendment by exerting substantial coercive pressure on social media companies such as Twitter to suppress disfavored speech like Plaintiff’s,” referring to former New York reporter Alex Berenson. Officials said they were paying Berenson $150,000 to settle the case, which was filed in 2023 against then-President Joe Biden, Pfizer board member Dr. Scott Gottlieb, and others. In exchange, Berenson moved to dismiss the case. “I'd like to thank the Trump administration for acknowledging the government’s unconstitutional actions against me in 2021 and standing for my First Amendment rights as a journalist and American,” Berenson told The Epoch Times in an email. The government under President Donald Trump already settled a case raising similar issues and involving multiple states, agreeing not to take actions “to threaten Social-Media Companies with some form of punishment (i.e., an adverse legal, regulatory, or economic government sanction) unless they remove, delete, suppress, or reduce, including through altering their algorithms, posted social-media content containing protected free speech.” Twitter banned Berenson in 2021 after he wrote in opposition to mandating COVID-19 vaccination because “it doesn’t stop infection or transmission.” Berenson and Twitter settled a different lawsuit arising from the same incidents, with Twitter acknowledging that it should not have banned the journalist. Emails disclosed in other litigation showed that U.S. officials during the Biden administration, as well as Gottlieb, who is also a former commissioner of the Food ...
Getty Images Introduction Back when I last covered The Wendy’s Company ( WEN ), I upgraded them to Strong Buy, initiating a position and highlighting their deep discount despite the strong cash flow, attractive and well-covered dividend yield, and significant turnaround potential. Despite reports of another takeover bid (not confirmed yet) sending the stock higher, WEN remains a Strong Buy, being ...
Getty Images Introduction Back when I last covered The Wendy’s Company ( WEN ), I upgraded them to Strong Buy, initiating a position and highlighting their deep discount despite the strong cash flow, attractive and well-covered dividend yield, and significant turnaround potential. Despite reports of another takeover bid (not confirmed yet) sending the stock higher, WEN remains a Strong Buy, being in a solid financial position and generating significant amounts of cash even during a pivotal year, with significant long-term re-rating potential regardless of a buyout as they work on internal improvements. Pivotal Year Begins The Wendy’s Company IR Wendy’s Q1 report came with a beat on the market’s revenue estimates but significant drops in almost everything else, with global systemwide sales down 5.5% (-7.3% in the US, +6% internationally), with the company advancing on its Project Fresh plans to accelerate US restaurant closures and redirect capital towards growth, value, and quality, opening 27 new restaurants internationally. Meanwhile, Wendy’s also announced a major franchise agreement to build up to 1000 restaurants across China while changing their restaurant design in an effort to revitalize the brand (alongside system optimization/reallocation moves), with the CEO highlighting some of their efforts during their Q1 Earnings Call while also working on the quality aspect: The first pillar of Project Fresh is brand revitalization, which is about reestablishing Wendy's as the highest quality choice in QSR and connecting with our customers in more culturally relevant and distinctive ways. (...) We are beginning to incorporate that into our menu and messaging efforts, which will increasingly show up throughout the year as we focus on the consumer segments that represent our greatest opportunities for growth. In January, we launched Biggie deals to provide everyday value that our customers can count on at $4, $6 and $8 price points. The Wendy’s Company IR Regarding the...
A police investigation is underway in the Philippines, with suspicions that the incident was staged to help Sen. Ronald dela Rosa escape. (Image credit: Aaron Favila)
A police investigation is underway in the Philippines, with suspicions that the incident was staged to help Sen. Ronald dela Rosa escape. (Image credit: Aaron Favila)
AiRWA ( YYAI ) will implement a 1-for-40 reverse stock split effective at the opening of trading on May 18, 2026. Outstanding shares will decrease from about 42.14M shares to roughly 1.05M shares after the split. YYAI shares fell 9.7% premarket. More on Connexa Sports Technologies Financial information for Connexa Sports Technologies
AiRWA ( YYAI ) will implement a 1-for-40 reverse stock split effective at the opening of trading on May 18, 2026. Outstanding shares will decrease from about 42.14M shares to roughly 1.05M shares after the split. YYAI shares fell 9.7% premarket. More on Connexa Sports Technologies Financial information for Connexa Sports Technologies
Outgoing health secretary declares Labour’s ‘plan for the NHS is working’ as hospitals hit key target Hospitals in England have hit a key target for improving the time it takes patients to get treatment, which prompted Wes Streeting to declare that Labour’s “plan for the NHS is working” before departing as health secretary . Streeting had told the NHS to ensure that hospitals treated at least 65% ...
Outgoing health secretary declares Labour’s ‘plan for the NHS is working’ as hospitals hit key target Hospitals in England have hit a key target for improving the time it takes patients to get treatment, which prompted Wes Streeting to declare that Labour’s “plan for the NHS is working” before departing as health secretary . Streeting had told the NHS to ensure that hospitals treated at least 65% of patients within 18 weeks by the end of March. New NHS England figures published on Thursday showed that hospitals did so, treating 65.3% of people on the NHS waiting list within that timeframe in March. Continue reading...
Ideal Power Inc (NASDAQ:IPWR, FRA:5ILA) is positioning its patented B-TRAN bidirectional semiconductor switch at the center of a major industry shift toward high-voltage DC power architectures, the company said Thursday. The news came as the Austin, Texas-based company reported first quarter...
Ideal Power Inc (NASDAQ:IPWR, FRA:5ILA) is positioning its patented B-TRAN bidirectional semiconductor switch at the center of a major industry shift toward high-voltage DC power architectures, the company said Thursday. The news came as the Austin, Texas-based company reported first quarter...
Cullinan Metals (CSE: CMT) ( OTCQB: CMTNF ) on Thursday said it appointed mining Executive Christopher Huggins as Chief Executive Officer, effective immediately. Huggins, who has more than 25 years of experience in mineral exploration, mining technology, and finance, succeeds interim CEO Aleem Fidai, who will remain a director of the company. Separately, Cullinan said it plans to issue up to 1.49 ...
Cullinan Metals (CSE: CMT) ( OTCQB: CMTNF ) on Thursday said it appointed mining Executive Christopher Huggins as Chief Executive Officer, effective immediately. Huggins, who has more than 25 years of experience in mineral exploration, mining technology, and finance, succeeds interim CEO Aleem Fidai, who will remain a director of the company. Separately, Cullinan said it plans to issue up to 1.49 million shares at a deemed price of $0.34 each to settle debt totaling about $505,272 with certain creditors. Insiders will participate in the debt settlement for about $182,678. The company also said its board adopted a 20% fixed omnibus equity incentive plan and granted 1.45 million restricted share units to certain officers, directors, and consultants, subject to shareholder and Canadian Securities Exchange approval. Source: Press Release More on Cullinan Metals Corp. Financial information for Cullinan Metals Corp.
Cisco stock could be a big artificial intelligence winner. Cisco said it has taken $5.3 billion of artificial-intelligence infrastructure orders from hyperscalers so far this fiscal year and raised its full-year expectations to orders of $9 billion, up from $5 billion. “Massive déjà vu here from 1990s—but it actually could be just beginning for Cisco as their investments in silicon and optics pay ...
Cisco stock could be a big artificial intelligence winner. Cisco said it has taken $5.3 billion of artificial-intelligence infrastructure orders from hyperscalers so far this fiscal year and raised its full-year expectations to orders of $9 billion, up from $5 billion. “Massive déjà vu here from 1990s—but it actually could be just beginning for Cisco as their investments in silicon and optics pay off,” Melius Research analyst Ben Reitzes wrote in a note late Wednesday.
The State Street Technology Select Sector SPDR ETF (NYSEMKT:XLK) offers a concentrated, low-cost play on S&P 500 tech, while the Vanguard Information Technology ETF (NYSEMKT:VGT) provides broader exposure. Both funds serve as core pillars for investors seeking aggressive growth through the information technology sector. While the State Street fund focuses exclusively on large-cap technology stocks...
The State Street Technology Select Sector SPDR ETF (NYSEMKT:XLK) offers a concentrated, low-cost play on S&P 500 tech, while the Vanguard Information Technology ETF (NYSEMKT:VGT) provides broader exposure. Both funds serve as core pillars for investors seeking aggressive growth through the information technology sector. While the State Street fund focuses exclusively on large-cap technology stocks within the S&P 500, the Vanguard fund casts a wider net across the broader U.S. equity market, including small- and mid-cap companies. This difference in scope influences everything from diversification to dividend output. Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield. Continue reading
Preliminary results from a preclinical study demonstrated statistically significant increase in MHC-I expression following SIL204 treatment in human pancreatic and non-small cell lung cancer cells harboring a KRAS mutation, supporting potential future evaluation alongside anti-PD-1 therapies including pembrolizumab (Keytruda®) Preliminary results from a preclinical study demonstrated statistically...
Preliminary results from a preclinical study demonstrated statistically significant increase in MHC-I expression following SIL204 treatment in human pancreatic and non-small cell lung cancer cells harboring a KRAS mutation, supporting potential future evaluation alongside anti-PD-1 therapies including pembrolizumab (Keytruda®) Preliminary results from a preclinical study demonstrated statistically significant increase in MHC-I expression following SIL204 treatment in human pancreatic and non-small cell lung cancer cells harboring a KRAS mutation, supporting potential future evaluation alongside anti-PD-1 therapies including pembrolizumab (Keytruda®)
Trump’s summit with Xi Jinping pulled the spotlight from the war in Iran that has left a key conduit for Middle East oil flows all but closed for more than two months. The Chinese leader signaled that Beijing is moving toward greater openness as traders look out for business deals and purchasing commitments from the world’s second-biggest economy. The relentless rally in technology stocks is showi...
Trump’s summit with Xi Jinping pulled the spotlight from the war in Iran that has left a key conduit for Middle East oil flows all but closed for more than two months. The Chinese leader signaled that Beijing is moving toward greater openness as traders look out for business deals and purchasing commitments from the world’s second-biggest economy. The relentless rally in technology stocks is showing little sign of cooling as a blockbuster share sale and Cisco earnings highlighted the momentum around artificial intelligence. The Opening Trade has everything you need to know as markets open across Europe. With analysis you won't find anywhere else, we break down the biggest stories of the day and speak to top guests who have skin in the game. Hosted by Anna Edwards, Guy Johnson and Tom Mackenzie. (Source: Bloomberg)